IBKS No2 SPAC
GL Pharm Tech Corp. provides generic drugs and incrementally modified drug (IMD) formulation technology to pharmaceutical companies in South Korea. The company offers IMD for gastritis, antidepressant, anorectic, and antibiotic indications. It also provides generic drugs for cardiovascular, urology, pain, anti-infection, gastric disease, diabetes, central nervous system disease, respiratory disea… Read more
IBKS No2 SPAC (204840) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -0.014x
Based on the latest financial reports, IBKS No2 SPAC (204840) has a cash flow conversion efficiency ratio of -0.014x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-288.62 Million) by net assets (₩20.01 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
IBKS No2 SPAC - Cash Flow Conversion Efficiency Trend (2015–2024)
This chart illustrates how IBKS No2 SPAC's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
IBKS No2 SPAC Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of IBKS No2 SPAC ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Nanexa AB
ST:NANEXA
|
0.175x |
|
Western Uranium & Vanadium Corp
OTCQX:WSTRF
|
-0.044x |
|
Keep Inc.
F:WZ2
|
N/A |
|
Allied Telesis Holdings K.K
OTCGREY:ATSKF
|
N/A |
|
Wanshih Electronic Co Ltd
TWO:6134
|
-0.054x |
|
PlayD Co. Ltd
KQ:237820
|
0.018x |
|
Indonesia Energy
NYSE MKT:INDO
|
-0.054x |
|
Atari S.A.
PA:ALATA
|
0.324x |
Annual Cash Flow Conversion Efficiency for IBKS No2 SPAC (2015–2024)
The table below shows the annual cash flow conversion efficiency of IBKS No2 SPAC from 2015 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩19.67 Billion | ₩-4.65 Billion | -0.236x | +22.80% |
| 2023-12-31 | ₩12.28 Billion | ₩-3.76 Billion | -0.306x | -288.18% |
| 2022-12-31 | ₩16.09 Billion | ₩-1.27 Billion | -0.079x | +41.51% |
| 2021-12-31 | ₩16.85 Billion | ₩-2.27 Billion | -0.135x | +27.62% |
| 2020-12-31 | ₩14.31 Billion | ₩-2.67 Billion | -0.186x | +58.96% |
| 2019-12-31 | ₩2.36 Billion | ₩-1.07 Billion | -0.454x | +6.69% |
| 2018-12-31 | ₩7.82 Billion | ₩-3.80 Billion | -0.486x | +24.43% |
| 2017-12-31 | ₩5.94 Billion | ₩-3.82 Billion | -0.644x | -38.10% |
| 2016-12-31 | ₩8.57 Billion | ₩-3.99 Billion | -0.466x | -161.72% |
| 2015-12-31 | ₩3.18 Billion | ₩2.40 Billion | 0.755x | -- |